Charles river finalizes agreement with cellphenomics, expanding 3d in vitro services for cancer therapy drug screening

Wilmington, mass. & berlin--(business wire)---- $crl #lifeatcrl--charles river expands portfolio of 3d in vitro testing services for oncology research with cellphenomics' proprietary pd3d tumor model platform.

CRL Ratings Summary

CRL Quant Ranking